FDA Drug Application (022267) for DEPAKOTE ER by ABBVIE INC

Back to FDA Applications sponsored by ABBVIE INC

Application Number022267
Product Number001
FormTABLET, EXTENDED RELEASE; ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDEPAKOTE ER
Active IngredientDIVALPROEX SODIUM



Back to FDA Applications sponsored by ABBVIE INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.